OSTP

Find the latest for OSTP company news

6 ways GPT Operator is changing PPC automation

GPT Operator isn't a complete solution. Yet. Here's where GPT Operator actually works in PPC applications - and where it falls short.

COEPTIS NexGenAI Affiliates Network & MarketLeverage Announce Strategic Partnership to Revolutionize AI-Powered Affiliate Marketing

This partnership gives COEPTIS access to AI-driven campaign management, predictive analytics, and automated outreach capabilities with MarketLeverage's 5,500 advertisers and 55,000 publishers, creating one of the most expansive and effective affiliate networks in the industryWEXFORD,

OpenAI lays out roadmap for GPT-4.5 and GPT-5 release

OpenAI CEO Sam Altman shared the roadmap for GPT-5 and GPT-4.5, and revealed that o3 will no longer launch as a standalone model.

OpenAI plans to simplify AI products in new road map for latest models, CEO Altman says

OpenAI will not release "o3" as a standalone artificial intelligence model, as the ChatGPT maker looks to simplify its products, CEO Sam Altman said on Wednesday.

OpenAI wants to take over your browser

Welcome back to Week in Review. This week we're diving into OpenAI's newly released AI agent, called Operator. We also look at where TikTok stands after

Cybersecurity 8month
India's AI-First HR Software - Pocket HRMS launches E-POSH Module utilizing AI for a Safer Workplace

Pocket HRMS, India's most innovative HR and payroll software developer, proudly announces the launch of its E-POSH module, setting a new benchmark in workplace safety and digital transformation. As a pioneer in the HR tech domain,

The Next Great Leap in AI Is Behind Schedule and Crazy Expensive

The startup has run into problem after problem on its new artificial-intelligence project, code-named Orion.

Petros Pharmaceuticals Featured in "New Era of Healthcare, AI, Data and Consumer Empowerment"

Petros Pharmaceuticals, Inc. ("Petros" or the "Company"), a company focused on expanding consumer access to medication through over the counter ("OTC") drug development programs,

Healthcare 9month